U.S. markets open in 2 hours 18 minutes

Cassava Sciences, Inc. (SAVA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
88.26+3.40 (+4.01%)
At close: 4:00PM EDT
91.48 +3.22 (3.65%)
Pre-Market: 07:12AM EDT
Sign in to post a message.
  • m
    matthew
    Look at 10-Q that just got released. This is the most bullish thing I’ve ever seen. Hyper Growth!!

    “On August 4, 2021, the Company completed the purchase of a two-building office complex in Austin, Texas, which will serve as its new corporate headquarters. This property is intended to accommodate the Company’s anticipated significant growth and expansion of its operations in the coming years. Company management expects to be hands-off with regards to property management. Maintenance, physical facilities, leasing, property management and other key responsibilities around property ownership will all be assumed by professional real-estate managers under long-term contract with the Company. The property purchase price was $21.9 million, exclusive of closing costs, funded with cash on hand.”
    Bullish
  • J
    John
    Something tells me the early earnings plus the building purchase means the “announcement” Remi mentioned is imminent. What a time to be a SAVA shareholder
    Bullish
  • A
    Archimedes
    The new property is huge news and besides accommodating our company's expected expansion and growth it has rental space that is currently occupied in the very trendy and marketable Austin, TX area. Omg, it just keeps getting better. We picked the right stock!
    Bullish
  • B
    BioPharmaInvestor
    This is how JNJ, Roche and Pfizer all got started.......Hold on tight to your valuable shares.....The institutions WANT.....your shares because Simufilam could eventually generate twice the sales of Humira with an expanded AD-CNS label.......Something for longs and shorts to ponder going forward.
    Bullish
  • A
    AD3
    -Buying a Huge building office
    -Remi Stating Hypergrowth
    -Aricept Era and exclusivity coming to an end by July next years
    -Pfe staff moving in Austin pretty sure
    -james kupiec (former pfe for 17yrs on board )
    -Barry purchasing 150 000 shrs at avg 56$

    Well everything is getting pretty clear here

    CASSAVAFIZZER uhmmm

    Will be easy to swap aricept with sumifilam in 12-18months from now

    Cheers 🍻

    Bullish AF!
    Bullish
  • B
    BioPharmaInvestor
    SAVA's upfront cash payment from a partnership deal could EXCEED......SAVA's current market cap if the deal involves exclusivity and next month's readout again shows cognitive improvements from month 9 to month 12.........Shorts are swimming in very dangerous waters.
  • J
    John
    Any half way serious biotech investor knows the limitations of an open label study. We get it, we need a phase 3. It’s coming. HOWEVER, the benefit of an open label is that the sponsor gets a real time look at the data. Ask yourself why SAVA would be talking about hypergrowth and buying new buildings and talking about a coming major announcement regarding funding of the data was bad. Extinction level event coming for shorts
    Bullish
  • J
    J. Kress
    Although I'd prefer that SAVA does not become a meme stock, the possibility exists. Low float, increased short interest, etc. I truly believe the hit piece drove this down, and now the smart money is accumulating. Why? Because biotech analysts and others knowledgeable in the Alzheimers field recognize Cassava as the one hope for patients. My point? Do not sell your shares. I bought Moderna at $150 awhile back and sold just over $200, and thought I was a hero with a $50 profit. I'm not leaving any money on the table with SAVA. Good luck to all longs.
  • N
    NeilB
    I’ve had the rugged pulled out a time two like we all have. I wasn’t convinced that a shelf wasn’t coming after the run up to $140, and I have voiced that. They have proven that they are listening to their shareholders collectively, reassuring that the cash burn is adequate. I applaud their transparency.
  • y
    yulita
    I’ve been buying and hold sava since it was $6, 8, 11, 61, added more yesterday $87.
  • p
    pueo
    i've been with SAVA since ptie, looking for a better opioid that resists abuse and addiction. lost some good friends to oxycontin's addictive nature. remoxy seemed to be the answer for non-addictive effective pain management. unfortunately, the fda was corrupted by oxycontin and remoxy had no chance as the fda was being criticized for allowing oxycontin to be sold without controls.

    now that remi seems to have enough cash and data to bring simufilam to market to help and save millions of alzheimer's sufferers, i am hoping he can do the same for people facing painful medical procedures or suffering from chronic excruciating pain by revisiting marketing remoxy.

    two buildings? hanging on to my sava for now.
  • e
    erik
    Page 29 of 80 on the sec 10-Q Filing....Leases
    We lease approximately 6,000 square feet of office space pursuant to a non-cancelable operating lease in Austin, TX that expires in April 2024. We
    also lease an additional 3,600 square feet of office space in Austin, Texas that expires on April 30, 2022.
    On August 4, 2021, we completed the purchase of a two-building office complex in Austin, Texas, which will serve as our new corporate headquarters.
    This property is intended to accommodate our anticipated significant growth and expansion of our operations in the coming years. Company management
    expects to be hands-off with regards to property management. Maintenance, physical facilities, leasing, property management and other key responsibilities
    around property ownership will all be assumed by professional real-estate managers under long-term contract with the Company. The property purchase
    price was $21.9 million, exclusive of closing costs, funded with cash on hand. The office complex measures approximately 90,000 rentable square feet. The
    property is currently 59% leased, before the effect of the Company occupying approximately 25% of the property in the near future. The seller is an
    independent third party not affiliated with the Company.
    Bullish
  • C
    Chester
    I know most of you don’t need the advice of an old man. But making it in investing is liken knowing good wine. You can invest in all the CBD, thc injected fruit juice companies to make a buck, even destroy the mental vision of the future with magic mushroom spiniatA, but you will never know the feeling of being part of something that saves reality like sava offers for those that can know no difference. Between the fabricated synthetics for kicks and the natural real processs for the sonnet of life.
  • S
    Spock
    Looks like we all thankfully forgot -very quickly today- about Pomerass & friends. Cheers to everyone for making it halfway through a much better week!
  • R
    Ron
    SAVA buys new Austin Headquarters
    Bullish
  • C
    Cecil
    Amazing to think that on January 1, 2020, Moderna was trading and $20.51. SAVA's day will come!
    Bullish
  • j
    jeff
    If Novavax can reach over $300 with no emergency approval and only a 70 million float for an outdated vaccine that is slow to market, think what a pill for AZ can do with no side affects?
    Bullish
  • A
    Anthony
    Investorplace author sticking to his $900 price target in a year.
  • S
    Sam
    I say it’s Pfizer. Albert Bourla saw how the great partnership with BTNX turned out for PFE. He is now loaded with billions.
  • R
    Richard
    Not much to say. Manipulation occurs. This stock should be 200+ right now. Remi will release data now in an unscheduled manner. Can't wait to see the maintenance study. And then of course BTD. Oh also partnership. And we are starting phase 3 soon. Lots of potential catalysts. Unfortunately we will have to wait. Which is the bio way. Without a buyout this companies stock can move much higher
    Bullish